287 related articles for article (PubMed ID: 22004671)
1. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Cone EJ; Clarke J; Tsanaclis L
J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
[TBL] [Abstract][Full Text] [Related]
3. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.
Heltsley R; Depriest A; Black DL; Crouch DJ; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
J Anal Toxicol; 2012 Mar; 36(2):75-80. PubMed ID: 22337775
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
[TBL] [Abstract][Full Text] [Related]
5. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
West R; Mikel C; Hofilena D; Guevara M
Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
[TBL] [Abstract][Full Text] [Related]
6. Urine drug testing of chronic pain patients: licit and illicit drug patterns.
Cone EJ; Caplan YH; Black DL; Robert T; Moser F
J Anal Toxicol; 2008 Oct; 32(8):530-43. PubMed ID: 19007501
[TBL] [Abstract][Full Text] [Related]
7. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
[TBL] [Abstract][Full Text] [Related]
8. Drug testing and adherence monitoring in pain management: Oral fluid testing.
Moore C
J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
[TBL] [Abstract][Full Text] [Related]
9. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
Marin SJ; Keith L; Merrell M; McMillin GA
J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
[TBL] [Abstract][Full Text] [Related]
10. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
[TBL] [Abstract][Full Text] [Related]
11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
[TBL] [Abstract][Full Text] [Related]
12. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
Truver MT; Palmquist KB; Swortwood MJ
J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Drugs in Oral Fluid Using LC-MS/MS.
Coulter CA; Moore CM
Methods Mol Biol; 2019; 1872():237-259. PubMed ID: 30350295
[TBL] [Abstract][Full Text] [Related]
14. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
15. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
16. Utility of oral fluid in compliance monitoring of opioid medications.
Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
[TBL] [Abstract][Full Text] [Related]
17. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
18. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid.
Wylie FM; Torrance H; Anderson RA; Oliver JS
Forensic Sci Int; 2005 Jun; 150(2-3):191-8. PubMed ID: 15944059
[TBL] [Abstract][Full Text] [Related]
19. The frequency of alcohol, illicit and licit drug consumption in the general driving population in South-East Hungary.
Institóris L; Tóth AR; Molnár A; Arok Z; Kereszty E; Varga T
Forensic Sci Int; 2013 Jan; 224(1-3):37-43. PubMed ID: 23149316
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume.
Gjerde H; Normann PT; Christophersen AS
J Anal Toxicol; 2010 Sep; 34(7):416-9. PubMed ID: 20822680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
